Vito J. Palombella is Chief Scientific Officer at INFINITY PHARMACEUTICALS, INC. (INFI). They have made 3 open-market trades across 2 companies since 2013, most recently 2023-09-08.
CIK 0001492805
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SURF | SELL | 2022-08-03 | 2022-08-05 | $1.72 | $8K | -1.1% | -25.7% | -31.3% |
| SURF | SELL | 2021-07-21 | 2022-01-14 | $6.10 | $321K | -18.5% | -16.4% | -39.6% |
| INFI | SELL | 2015-06-15 | 2015-06-16 | $10.97 | $52K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2014-12-15 | 2014-12-16 | $16.32 | $77K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2014-11-26 | 2014-11-28 | $15.00 | $71K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2014-07-01 | 2014-07-02 | $12.87 | $11K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2014-02-25 | 2014-02-27 | $15.00 | $71K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2014-01-02 | 2014-01-06 | $13.52 | $10K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2013-09-27 | 2013-09-30 | $17.28 | $82K | -22.9% | -10.3% | -10.3% |
| INFI | SELL · 10b5-1 | 2013-06-20 | 2013-06-21 | $18.53 | $429K | -22.9% | -10.3% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.